February 2007 Briefing - Urology

Here are what the editors at HealthDay consider to be the most important developments in Urology for February 2007. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Direct-to-Consumer Ads Should Spur Doc-Patient Discussions

FRIDAY, Feb. 23 (HealthDay News) -- Direct-to-consumer drug ads should be a topic of discussion between physicians and patients, including the expectations and misperceptions that can result from such advertising, according to a Michigan physician. The "medicalization" of society, represented by direct-to-consumer drug ads, patient empowerment and changing perceptions of illness, is the subject of six essays published Feb. 24 in a special section of The Lancet.

Full Text (subscription or payment may be required)

Periodontitis Predicts Kidney Disease in Type 2 Diabetics

THURSDAY, Feb. 22 (HealthDay News) -- Periodontitis is a predictor of end-stage renal disease in patients with type 2 diabetes, researchers report in the February issue of Diabetes Care.

Abstract
Full Text (subscription or payment may be required)

Laparoscopic Living Donor Nephrectomy Problems Rare

FRIDAY, Feb. 16 (HealthDay News) -- Although complication rates of 16 percent or greater have been reported, a study at one U.S. hospital suggests that laparoscopic living donor nephrectomies can have a quick recovery with a low 4 percent complication rate, according to a report in the January issue of Urology.

Abstract
Full Text (subscription or payment may be required)

Gross Hematuria in Children Usually Has Benign Cause

THURSDAY, Feb. 15 (HealthDay News) -- When gross hematuria occurs in pediatric patients, it's more likely to occur in boys than girls and it's usually due to benign causes, according to a clinical review published in the January issue of Urology.

Abstract
Full Text

Prostate Cancer Patients Need Fertility Counseling

WEDNESDAY, Feb. 14 (HealthDay News) -- Many men with newly diagnosed prostate cancer, regardless of their age, are interested in preserving their fertility for the future, researchers report in the January issue of Urology.

Abstract
Full Text

High-Power Lasers Safely Treat Large Renal Stones

WEDNESDAY, Feb. 14 (HealthDay News) -- Holmium-yttrium-aluminum-garnet (YAG) laser lithotripsy, already widely used for the treatment of a range of diseases of the urinary tract, is a safe and effective treatment for large renal stones, according to a report published in the January issue of Urology.

Abstract
Full Text (subscription or payment may be required)
Editorial

Hemodialysis Patients Have Poor Hip Surgery Outcome

FRIDAY, Feb. 9 (HealthDay News) -- Frequent complications and a higher mortality are often the result of hip fracture surgery in end-stage renal disease patients who are on hemodialysis, according to a report in the February issue of the Journal of Bone & Joint Surgery.

Abstract
Full Text (subscription or payment may be required)

PSA Test Predicts Prostate Cancer Up to 25 Years Later

FRIDAY, Feb. 9 (HealthDay News) -- Measuring the levels of prostate-specific antigen in middle-aged men may accurately predict long-term risk of prostate cancer, according to a report in the Feb. 1 issue of the Journal of Clinical Oncology.

Abstract
Full Text (subscription or payment may be required)

Overweight Women at Risk for Incontinence in Middle-Age

WEDNESDAY, Feb. 7 (HealthDay News) -- Nearly half of women aged 42 to 52 experience urinary incontinence at least once a month, researchers report in the Feb. 1 issue of the American Journal of Epidemiology. Compared with incontinence in old age, the same condition in mid-life tends to be milder and excess body weight and diabetes are risk factors.

Abstract
Full Text

More U.S. Patients Over Age 80 Are Starting Dialysis

TUESDAY, Feb. 6 (HealthDay News) -- Since 1996, increasing numbers of people in their 80s and 90s have initiated dialysis, but their odds of one-year survival are still only about 50 percent, according to a report published in the Feb. 6 issue of the Annals of Internal Medicine.

Abstract
Full Text (subscription or payment may be required)

Drug Improves Outcomes in Patients Undergoing CABG

MONDAY, Feb. 5 (HealthDay News) -- Nesiritide, which is identical to B-type natriuretic peptide secreted by the ventricles, improves renal function and reduces length of hospital stay and mortality in patients undergoing coronary artery bypass grafting (CABG), according to study findings published in the Feb. 13 issue of the Journal of the American College of Cardiology.

Abstract
Full Text (subscription or payment may be required)
Editorial

Urine Nitric Oxide Predicts Survival After Lung Injury

THURSDAY, Feb. 1 (HealthDay News) -- Patients with acute lung injury or acute respiratory distress syndrome who have elevated levels of nitric oxide in the urine have improved survival compared to those who do not, researchers report in the February issue of the American Journal of Respiratory and Critical Care Medicine.

Abstract
Full Text (subscription or payment may be required)

Physician's Briefing